Vaccine Therapy in Treating Patients With Stage IV Breast Cancer
| 針對症狀 | HER2-positive Breast Cancer |
| 臨床試驗編號 | NCT00791037 |
| 臨床階段 | Phase I/II |
| 臨床試驗位址 | Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium |
| 目前研究進度 | This study is currently recruiting participants. |
| 試驗開始日期 | November 13, 2008 |
| 試驗開始日期 | October 26, 2012 |
| 臨床目的 |
This phase I/II trial is studying the side effects and best dose of adoptive T cell therapy in treating patients with stage IV breast cancer. Vaccines are given to patient prior the expansion of a person's white blood cells may help the body build an effective immune response to kill tumor cells that overexpress human epidermal growth factor receptor 2 (HER2) This phase I/II trial is studying the side effects and best dose of adoptive T cell therapy in treating patients with stage IV breast cancer. Vaccines are given to patient prior the expansion of a per |